SM

Santosh Mahadev Chilgar

Active Director Managing Director DIN 02026184
DIN 02026184 First appointment Apr 2008 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Apr 2008
Shareholding value •••• Premium profile

About Santosh Mahadev Chilgar

Data last updated:

Santosh Mahadev Chilgar is a Managing Director at Mahapa Chemicals Private Limited (since 2008), Director at Ellivent Healthcare Private Limited (since 2014) and Director at Klops Life Sciences Private Limited (since 2016). The companies operate in Chemicals and Materials, Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹2.58 Cr; the largest is Mahapa Chemicals Private Limited at ₹2.54 Cr (FY 2025). Earlier, Santosh Mahadev Chilgar was a Director at Satyahari Organochem Private Limited (2011–2019).

DIN 02026184
Primary Designation Managing Director
Industry Chemicals and Materials
First Appointment 02 Apr 2008
Oldest Company Age 18 yrs
Largest company Mahapa Chemicals Private Limited · ₹2.54 Cr (FY 2025)
Combined revenue ₹2.58 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mahapa Chemicals Private Limited U24100MH2008PTC180728
Managing Director02 Apr 20082008₹2.54 Cr (FY 2025)Active
Ellivent Healthcare Private Limited U74900MH2014PTC255218
Director02 Apr 20142014₹3.9 Lakh (FY 2020)Active
Klops Life Sciences Private Limited U24290MH2016PTC280235
Director26 Apr 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Satyahari Organochem Private Limited U24100MH2011PTC215919
Director07 Apr 20112011₹9.22 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mahapa Chemicals Private Limited
Klops Life Sciences Private Limited
Ellivent Healthcare Private Limited
Satyahari Organochem Private Limited
Premium access

Shareholding and investment profile for Santosh Mahadev Chilgar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Mahadev Chilgar

Santosh Mahadev Chilgar currently holds 3 directorships: Mahapa Chemicals Private Limited (Managing Director, since 02 Apr 2008, revenue ₹2.54 Cr (FY 2025)); Ellivent Healthcare Private Limited (Director, since 02 Apr 2014, revenue ₹3.9 Lakh (FY 2020)); Klops Life Sciences Private Limited (Director, since 26 Apr 2016).

Santosh Mahadev Chilgar was first appointed on 02 Apr 2008 as Managing Director at Mahapa Chemicals Private Limited. The most recent appointment on record is 26 Apr 2016 at Klops Life Sciences Private Limited.

The 2 current companies of Santosh Mahadev Chilgar that report revenue have a combined latest revenue of ₹2.58 Cr: Mahapa Chemicals Private Limited ₹2.54 Cr (FY 2025); Ellivent Healthcare Private Limited ₹3.9 Lakh (FY 2020).

Santosh Mahadev Chilgar held 1 earlier board appointment: Satyahari Organochem Private Limited (Director, 07 Apr 2011 to 10 May 2019).

The current boards of Santosh Mahadev Chilgar's companies include Sanjay Haribhau Yadav (Mahapa Chemicals Private Limited), Ram Mahadev Chilgar (Ellivent Healthcare Private Limited), Sunil Jagannath Maharnawar (Ellivent Healthcare Private Limited), Suresh Ramchandra Bhadwale (Ellivent Healthcare Private Limited), Kirti Lakshmikant Nitlikar (Klops Life Sciences Private Limited), Lakshmikant Hanumant Rao Nitlikar (Klops Life Sciences Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available